Acute Leukemias of Ambiguous Lineage
5 clinical trials · Condition
◉ Watch Acute Leukemias of Ambiguous Lineage
| Record | Firm | Date |
|---|---|---|
| S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia (NCT01925131) | SWOG Cancer Research Network | 2014-06-13 |
| Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation (NCT01371656) | Children's Oncology Group | 2011-09-01 |
| MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia (NCT01231919) | National Cancer Institute (NCI) | 2011-01-01 |
| Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia (NCT01132573) | National Cancer Institute (NCI) | 2010-04-01 |
| Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia (NCT00933985) | National Cancer Institute (NCI) | 2009-06-01 |
Track Acute Leukemias of Ambiguous Lineage automatically
Every clearance here is in the API, with alerts when new ones post.